Theravance Biopharma Stock Price History
TBPH Stock | USD 8.97 0.11 1.24% |
If you're considering investing in Theravance Stock, it is important to understand the factors that can impact its price. As of today, the current price of Theravance Biopharma stands at 8.97, as last reported on the 26th of February, with the highest price reaching 9.14 and the lowest price hitting 8.78 during the day. Theravance Biopharma owns Efficiency Ratio (i.e., Sharpe Ratio) of close to zero, which indicates the firm had a close to zero % return per unit of risk over the last 3 months. Theravance Biopharma exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Theravance Biopharma's Risk Adjusted Performance of (0.01), coefficient of variation of (5,255), and Variance of 6.59 to confirm the risk estimate we provide.
Theravance Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Theravance |
Sharpe Ratio = -0.0074
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | TBPH |
Estimated Market Risk
2.62 actual daily | 23 77% of assets are more volatile |
Expected Return
-0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Theravance Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Theravance Biopharma by adding Theravance Biopharma to a well-diversified portfolio.
Theravance Biopharma Stock Price History Chart
There are several ways to analyze Theravance Stock price data. The simplest method is using a basic Theravance candlestick price chart, which shows Theravance Biopharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | January 24, 2025 | 10.47 |
Lowest Price | January 16, 2025 | 8.44 |
Theravance Biopharma February 26, 2025 Stock Price Synopsis
Various analyses of Theravance Biopharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Theravance Stock. It can be used to describe the percentage change in the price of Theravance Biopharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Theravance Stock.Theravance Biopharma Price Daily Balance Of Power | 0.31 | |
Theravance Biopharma Price Rate Of Daily Change | 1.01 | |
Theravance Biopharma Accumulation Distribution | 19,644 | |
Theravance Biopharma Price Action Indicator | 0.07 |
Theravance Biopharma February 26, 2025 Stock Price Analysis
Theravance Stock Price History Data
The price series of Theravance Biopharma for the period between Thu, Nov 28, 2024 and Wed, Feb 26, 2025 has a statistical range of 2.03 with a coefficient of variation of 4.45. The price distribution for the period has arithmetic mean of 9.47. The median price for the last 90 days is 9.48.Open | High | Low | Close | Volume | ||
02/25/2025 | 8.84 | 9.14 | 8.78 | 8.97 | 498,732 | |
02/24/2025 | 9.30 | 9.40 | 8.84 | 8.86 | 274,365 | |
02/21/2025 | 9.74 | 9.74 | 9.27 | 9.32 | 253,974 | |
02/20/2025 | 9.71 | 10.05 | 9.61 | 9.66 | 234,075 | |
02/19/2025 | 9.47 | 9.76 | 9.47 | 9.75 | 247,900 | |
02/18/2025 | 9.70 | 9.88 | 9.41 | 9.47 | 131,964 | |
02/14/2025 | 9.51 | 9.65 | 9.40 | 9.61 | 128,499 | |
02/13/2025 | 9.45 | 9.60 | 9.27 | 9.48 | 147,103 | |
02/12/2025 | 8.91 | 9.40 | 8.90 | 9.36 | 188,238 | |
02/11/2025 | 9.08 | 9.49 | 8.85 | 9.04 | 132,304 | |
02/10/2025 | 9.39 | 9.53 | 9.11 | 9.12 | 172,746 | |
02/07/2025 | 9.51 | 9.56 | 9.28 | 9.30 | 209,660 | |
02/06/2025 | 9.73 | 9.76 | 9.33 | 9.51 | 307,609 | |
02/05/2025 | 9.55 | 9.80 | 9.55 | 9.72 | 123,953 | |
02/04/2025 | 9.44 | 9.54 | 9.39 | 9.43 | 99,090 | |
02/03/2025 | 9.25 | 9.59 | 9.23 | 9.47 | 120,031 | |
01/31/2025 | 9.68 | 9.68 | 9.27 | 9.38 | 234,929 | |
01/30/2025 | 9.63 | 9.76 | 9.59 | 9.67 | 96,279 | |
01/29/2025 | 9.79 | 9.79 | 9.46 | 9.63 | 109,140 | |
01/28/2025 | 9.67 | 9.88 | 9.60 | 9.83 | 150,224 | |
01/27/2025 | 10.46 | 10.46 | 9.62 | 9.67 | 455,047 | |
01/24/2025 | 9.65 | 10.90 | 9.62 | 10.47 | 508,066 | |
01/23/2025 | 9.26 | 9.68 | 9.24 | 9.67 | 173,993 | |
01/22/2025 | 9.10 | 9.45 | 8.94 | 9.36 | 219,253 | |
01/21/2025 | 8.62 | 9.19 | 8.61 | 9.15 | 284,522 | |
01/17/2025 | 8.53 | 8.59 | 8.41 | 8.58 | 166,562 | |
01/16/2025 | 8.62 | 8.62 | 8.35 | 8.44 | 242,283 | |
01/15/2025 | 8.67 | 8.86 | 8.61 | 8.61 | 153,845 | |
01/14/2025 | 8.61 | 8.70 | 8.46 | 8.53 | 180,211 | |
01/13/2025 | 8.76 | 8.76 | 8.55 | 8.57 | 142,329 | |
01/10/2025 | 8.99 | 9.05 | 8.68 | 8.78 | 208,167 | |
01/08/2025 | 9.25 | 9.38 | 8.99 | 9.05 | 154,996 | |
01/07/2025 | 9.19 | 9.35 | 9.04 | 9.25 | 163,890 | |
01/06/2025 | 9.30 | 9.44 | 9.14 | 9.19 | 177,429 | |
01/03/2025 | 9.30 | 9.56 | 9.29 | 9.31 | 128,403 | |
01/02/2025 | 9.46 | 9.46 | 9.23 | 9.28 | 140,930 | |
12/31/2024 | 9.48 | 9.55 | 9.34 | 9.41 | 151,981 | |
12/30/2024 | 9.61 | 9.72 | 9.44 | 9.47 | 111,213 | |
12/27/2024 | 9.82 | 9.91 | 9.54 | 9.59 | 121,239 | |
12/26/2024 | 9.80 | 9.92 | 9.73 | 9.86 | 135,661 | |
12/24/2024 | 9.82 | 9.89 | 9.72 | 9.85 | 37,942 | |
12/23/2024 | 9.59 | 10.00 | 9.53 | 9.79 | 152,704 | |
12/20/2024 | 9.65 | 9.83 | 9.56 | 9.59 | 310,234 | |
12/19/2024 | 9.68 | 9.90 | 9.63 | 9.73 | 241,837 | |
12/18/2024 | 10.00 | 10.08 | 9.62 | 9.71 | 212,954 | |
12/17/2024 | 9.78 | 9.99 | 9.65 | 9.96 | 249,829 | |
12/16/2024 | 9.87 | 10.06 | 9.77 | 9.80 | 181,109 | |
12/13/2024 | 9.84 | 10.00 | 9.74 | 9.88 | 220,768 | |
12/12/2024 | 9.94 | 10.11 | 9.74 | 9.87 | 191,136 | |
12/11/2024 | 10.08 | 10.10 | 9.96 | 10.04 | 129,668 | |
12/10/2024 | 9.97 | 10.15 | 9.94 | 10.08 | 214,765 | |
12/09/2024 | 9.89 | 10.25 | 9.89 | 9.99 | 217,550 | |
12/06/2024 | 9.81 | 10.01 | 9.81 | 9.88 | 132,468 | |
12/05/2024 | 9.58 | 9.88 | 9.55 | 9.84 | 166,283 | |
12/04/2024 | 9.84 | 9.98 | 9.55 | 9.59 | 198,084 | |
12/03/2024 | 9.45 | 9.84 | 9.37 | 9.84 | 240,477 | |
12/02/2024 | 9.14 | 9.53 | 9.14 | 9.44 | 325,663 | |
11/29/2024 | 9.46 | 9.49 | 9.20 | 9.25 | 91,398 | |
11/27/2024 | 9.32 | 9.56 | 9.25 | 9.42 | 255,336 | |
11/26/2024 | 9.50 | 9.50 | 9.20 | 9.24 | 182,269 | |
11/25/2024 | 9.52 | 9.76 | 9.47 | 9.47 | 240,130 |
About Theravance Biopharma Stock history
Theravance Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Theravance is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Theravance Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Theravance Biopharma stock prices may prove useful in developing a viable investing in Theravance Biopharma
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. Theravance Biopharma, Inc. was incorporated in 2013 and is based in George Town, the Cayman Islands. Theravance Bio is traded on NASDAQ Exchange in the United States.
Theravance Biopharma Stock Technical Analysis
Theravance Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Sign In To Macroaxis Now
Sign In To MacroaxisSign in to explore Macroaxis' wealth optimization platform and fintech modules |
All Next | Launch Module |
Theravance Biopharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Theravance Biopharma's price direction in advance. Along with the technical and fundamental analysis of Theravance Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Theravance to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.01) | |||
Jensen Alpha | (0.06) | |||
Total Risk Alpha | (0.08) | |||
Treynor Ratio | (0.13) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Theravance Stock analysis
When running Theravance Biopharma's price analysis, check to measure Theravance Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theravance Biopharma is operating at the current time. Most of Theravance Biopharma's value examination focuses on studying past and present price action to predict the probability of Theravance Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theravance Biopharma's price. Additionally, you may evaluate how the addition of Theravance Biopharma to your portfolios can decrease your overall portfolio volatility.
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
CEOs Directory Screen CEOs from public companies around the world | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |